Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¹æ±¤Á¾¾ç¿¡¼­ÀÇ Thiotepa ±¹¼Ò¿ä¹ýÀÇ ÀÓ»óÀû °üÂû A Clinical Observation of the Intravesical Thiotepa in Bladder Cancer

´ëÇѺñ´¢±â°úÇÐȸÁö 1981³â 22±Ç 2È£ p.195 ~ 199
¼Ò¼Ó »ó¼¼Á¤º¸
¹Î±Ù½Ä/Min KS ¹Ú±ÔÈ«/Park KH

Abstract


"Primary transitional cell carcinoma of the bladder was treated with prophylactic and therapeutic Intravesical thiotepa in 7 cases. In 5 cases of stage A tumor, postoperative follow up was averaged 10.8 months and 4 cases were tumor free (80%). In 2 cases of infiltrating tumor, the instillation was not effective. Thiotepa can be given safely in the 7 days post-operative period and no leukopenia and bladder irritation symptoms were occurred."

Å°¿öµå

¹æ±¤Á¾¾ç; ¹æ±¤³»È­Çпä¹ý; Intravesical chemotherapy; thiotepa; bladder cancer

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS